FSEA Insider Filing: 1,200-Share Purchase; 19,593 Options/Restricted Shares Disclosed
Rhea-AI Filing Summary
Mark P. Boulanger, a director of First Seacoast Bancorp (FSEA), reported a purchase of 1,200 shares of the issuer's common stock on 09/03/2025 at $11.47 per share. After the reported purchase, the filing shows 6,501 shares held indirectly in an IRA and a reported disposition of 7,759 shares. The report also discloses two outstanding option grants exercisable for 9,343 shares (exercise price $8.06, expiring 05/25/2033) and 10,250 shares (exercise price $9.29, expiring 12/02/2034), both held directly. Vesting notes state restricted stock and the second option tranche vest at 33 1/3% per year commencing 12/02/2025, while the first option tranche vests at the same annual rate commencing 05/25/2024. The form is signed via power of attorney on 09/03/2025.
Positive
- Director purchase of 1,200 shares at $11.47, signaling an addition to insider holdings
- Substantial exercisable options reported (9,343 and 10,250 shares) which align management incentives with shareholders
- Clear vesting schedules for restricted stock and options (33 1/3% per year), reducing immediate dilution risk
Negative
- Reported disposition of 7,759 shares reduces insider's net holdings and lacks contextual detail in this filing
- Signature via power of attorney (Victor L. Cangelosi) instead of the reporting person, which may reduce immediacy of direct attestation
Insights
TL;DR: Director bought 1,200 shares and holds material in-the-money options, with structured vesting schedules.
The Form 4 shows an open-market purchase of 1,200 common shares at $11.47, increasing the director's reported indirect IRA holdings to 6,501 shares. The filing also records a disposition of 7,759 shares without further detail on timing or rationale. Notably, the reporting person holds 9,343 options at $8.06 (exercisable, expiring 2033) and 10,250 options at $9.29 (exercisable from 12/02/2025, expiring 2034). Both option grants and restricted shares have multi-year vesting (33 1/3% per year), which affects future insider supply and potential dilution. These option strike prices are below the reported purchase price, indicating existing in-the-money positions for the director.
TL;DR: Routine insider activity with POA signature; vesting schedules and a share disposition warrant disclosure clarity.
The filing is consistent with standard director compensation and insider reporting: option grants with staged vesting and a restricted share schedule. The signature was executed by an attorney-in-fact, which is permitted but should be transparent to shareholders. The reported disposition of 7,759 shares appears material to the director's net position yet lacks context in this filing (e.g., sale date, proceeds). For governance transparency, accompanying disclosures (if any) would clarify whether transactions relate to planned sales, taxes, or other causes.